Elevalift: office-based, non-surgical laser scrotoplasty

The aging process and certain pathological conditions can result in scrotal skin laxity, redundancy, and aesthetic concerns. Epidemiological evidence suggests that scrotal laxity is more common in men over 50 years of age and affects up to 25-30% of patients after significant weight loss. Current treatments are limited; scrotoplasty remains the standard surgical option, but it is associated with scarring, recovery time, and potential complications. Endolift^®, a protocol developed by Eufoton^® (Trieste, Italy) and applied as the Elevalift protocol for the genital area, is a minimally invasive, laser-assisted technique that has demonstrated efficacy in inducing collagen remodeling, skin tightening, and tissue retraction in various anatomical regions. This publication reports on the first clinical experience conducted at the San Isidro Central Hospital “Melchor Angel Posse” (Buenos Aires, Argentina), evaluating the application of Endolift^®/Elevalift in scrotal tissue, with a focus on the mechanisms of action, tissue characteristics, ethical compliance, safety profile, and preliminary results. All procedures were performed in accordance with the Declaration of Helsinki, and written informed consent was obtained from all patients. Approval was granted by the Institutional Bioethics Committee.